NBER WORKING PAPER SERIES

INVESTMENT SUBSIDIES AND THE ADOPTION OF ELECTRONIC MEDICAL
RECORDS IN HOSPITALS
David Dranove
Craig Garthwaite
Bingyang Li
Christopher Ody
Working Paper 20553
http://www.nber.org/papers/w20553

NATIONAL BUREAU OF ECONOMIC RESEARCH
1050 Massachusetts Avenue
Cambridge, MA 02138
October 2014

The views expressed herein are those of the authors and do not necessarily reflect the views of the
National Bureau of Economic Research.
NBER working papers are circulated for discussion and comment purposes. They have not been peerreviewed or been subject to the review by the NBER Board of Directors that accompanies official
NBER publications.
¬© 2014 by David Dranove, Craig Garthwaite, Bingyang Li, and Christopher Ody. All rights reserved.
Short sections of text, not to exceed two paragraphs, may be quoted without explicit permission provided
that full credit, including ¬© notice, is given to the source.

Investment Subsidies and the Adoption of Electronic Medical Records in Hospitals
David Dranove, Craig Garthwaite, Bingyang Li, and Christopher Ody
NBER Working Paper No. 20553
October 2014
JEL No. H2,I1,O33
ABSTRACT
In February 2009 the U.S. Congress unexpectedly passed the Health Information Technology for Economic
and Clinical Health Act (HITECH). HITECH provides up to $27 billion to promote adoption and appropriate
use of Electronic Medical Records (EMR) by hospitals. We measure the extent to which HITECH
incentive payments spurred EMR adoption by independent hospitals. Adoption rates for all independent
hospitals grew from 48 percent in 2008 to 77 percent by 2011. Absent HITECH incentives, we estimate
that the adoption rate would have instead been 67 percent in 2011. When we consider that HITECH
funds were available for all hospitals and not just marginal adopters, we estimate that the cost of generating
an additional adoption was $48 million. We also estimate that in the absence of HITECH incentives,
the 77 percent adoption rate would have been realized by 2013, just 2 years after the date achieved
due to HITECH.

David Dranove
Department of Management and Strategy
Kellogg School of Management
Northwestern University
2001 Sheridan Road
Evanston, IL 60208
d-dranove@kellogg.northwestern.edu
Craig Garthwaite
Department of Management and Strategy
Kellogg School of Management
Northwestern University
2001 Sheridan Road
Evanston, IL 60208
and NBER
c-garthwaite@kellogg.northwestern.edu

Bingyang Li
Northwestern University
Kellogg School of Management
bingyang-li@kellogg.northwestern.edu
Christopher Ody
Department of Management and Strategy
Kellogg School of Management
Northwestern University
2001 Sheridan Road
Evanston, IL 60208
chris.ody@gmail.com

1. Introduction
Critics of the United States health sector have long pointed to its combination of high costs and
poor outcomes, such as a high rate of medical errors (IOM, 2001). An often discussed source of
these problems is the relative low utilization of information technology compared to other industries
(Gartner, 2010). Many health policy analysts and academics suggest that the widespread adoption of
Electronic Medical Records (EMR) will transform the US healthcare system, simultaneously
reducing costs and improving outcomes (Hillestad et al., 2005; Buntin and Cutler, 2009). Several
studies suggest that increasing the use of EMR will increase efficiency and either decrease health care
expenditures, increase quality, or ideally both (McCullough et al., 2010; Miller and Tucker, 2011;
Freedman et al., 2014). Summarizing this literature, Buntin et al. (2011) found that over 90 percent
of studies found positive outcomes from EMR.
Despite these purported benefits, EMR adoption has, until recently, been largely confined to
large healthcare systems; smaller and independent hospitals, as well as other medical providers, have
remained on the sidelines. This suggests that either (a) there is a meaningful market failure that
creates a separation between the private and social benefits of EMR, or (b) many providers are
unconvinced about the benefits of EMR and have taken a ‚Äúwait-and-see‚Äù approach to this
investment decision.
Several unique features of the health market could cause a market failure with respect to
EMR adoption. For example, hospitals have found that being a high quality provider has a relatively
weak relationship to patient volume (Cutler, Huckman, and Landrum, 2004). The lack of a strong
volume response limits the potential profits from investments in quality. In addition, the existing
reimbursement system for most hospitals means much of the lower costs resulting from more
efficient care or better health outcomes flows to other entities. Absent an increased use of bundled
payments or more effective shared savings programs, hospitals are unable to fully capture the value
created by their spending on EMR. Instead, these benefits are split across a wide variety of public
and private payers, none of which individually has the incentive to increase reimbursement rates to
the level necessary to cover the costs of EMR.
Given the potential collective action problem, there could be a case for taxpayer subsidies
for EMR. This would alter the benefit/cost calculus for potential adopters, leading more providers
to conclude that benefits outweigh the (now subsidized) costs. This may be a justification for the
United States government‚Äôs heavy involvement in promoting the adoption of these benefits. These
efforts culminated in the 2009 passage of the Health Information Technology for Economic and
1

Clinical Health Act (henceforth, simply HITECH). HITECH provides up to $27 billion to promote
adoption of EMR and encourage the adoption and what regulators have described as the
‚Äúmeaningful use‚Äù of these systems by hospitals and physicians. 1 HITECH also specifies future cuts
to Medicare reimbursement rates for hospitals that do not maintain meaningful use standards
(ARRA, 2009).
Of course, a large number of providers failing to adopt EMR is not conclusive evidence of a
market failure. Many hospitals may have remained on the EMR sidelines because adoption costs are
high and they are not convinced that these systems will deliver the promised benefits. Indeed, while
many studies have found positive effects from EMR, the magnitude of the cost savings are, at best,
modest in comparison to the large installation costs (Agha, 2014; Lee et al., 2014; Himmelstein et al.,
2010). Other studies find that the quality improvements are fairly small or limited to specific
circumstances (DesRoches et al., 2009; Himmelstein et al., 2010). Some studies reveal a great deal of
heterogeneity in the benefits across hospitals and areas (McCullough et al., 2010; Dranove et al.,
2014). It also could be that the technology itself, or the knowledge about how best to implement the
existing products, is improving over time. If any or all of these factors are in play, then many
providers will choose not to adopt EMR at any given time. We might instead expect the relatively
smooth pattern of adoption that existed in the market prior to HITECH. If this were the case,
investment subsidies would simply shift investments in time and not change the ultimate adoption
decisions of firms. Moreover, subsidizing the installation of EMR might cause inefficiently high
adoption rates at a time when many hospitals are struggling to find how best to extract the benefits
of the technology.
Regardless of the merits of EMR or the cause of the lack of widespread adoption to date, it
is not immediately clear that HITECH subsidies would materially affect the investment decisions of
private firms. Prior research suggests that, despite their intentions, such subsidies may not actually
stimulate private investment. Peltzman (1973) introduces the notion that government subsidies
might crowd-out private investment, and provides evidence of dollar-for-dollar crowd out in
investments in higher education. Most of the subsequent research evidence also casts doubt on
effectiveness of government subsidies for promoting aggregate private investment. For example,
reviews of national ‚Äúindustrial policies,‚Äù in which nations subsidize capital investments in specific
sectors, find no connection between sector subsidies and sector capital accumulation (Pack and
Saggi, 2006). Other studies fail to reject 100 percent crowd out from government R&D subsidies
1

We explain the meaningful use standard in detail in Section 2.

2

(Wallsten, 2000; Lach, 2002). On the other hand, Gonzalez and Pazo (2008) find that public
subsidies for R&D do not produce 100 percent crowd-out of private R&D.
Tax incentives, which are of course closely related to investment subsidies, also seem to have
little net effect on investments. In a review article, Hanlon and Heitzman (2010) state ‚Äúthe literature
has had little success documenting a link between tax incentives and investment.‚Äù In an earlier
review of the research on tax policy, Hassett and Hubbard (2002) state: ‚Äú[t]he apparent inability of
tax incentives to stimulate aggregate investment spending is one of the major puzzles in the
empirical investment literature.‚Äù Goolsbee (1998) offers one potential explanation for some of these
findings: government subsidies may fail to spur investment because they are captured by capital
suppliers through higher prices. A similar concern is relevant in our setting, as the EMR market is
concentrated, with the top seven vendors holding a market share of 75 percent with even higher
concentration in various hospital segments. 2 It is therefore possible that vendors captured much of
these HITECH incentive payments through increased prices.
In this paper we measure the extent to which the HITECH incentive payments spurred
EMR adoption. Applying the rules governing HITECH payments to information from annual
hospital cost reports, we calculate each hospital‚Äôs expected HITECH incentive payments and
estimate the effect of these incentives on adoption. 3 Our research setting is somewhat different than
most of these earlier studies of government subsidies on investments in other settings. HITECH
represents a large lump sum subsidy for a large fixed cost investment, whereas most of the existing
research examines marginal responses to marginal subsidies and tax incentives. In addition, we are
able to document the timing of investments, so we can assess whether the incentive payments
increase aggregate investments or simply change the timing of the investment decision. If the
incentives simply shift forward the timing of the investments they likely provide fewer welfare
benefits than if they change the ultimate adoption decision of a firm.
As we discuss below, HITECH subsidies did not merely target new adopters. Hospitals that
had previously adopted EMR was also eligible for incentive payments, in part as a way to encourage
‚Äúmeaningful use.‚Äù We therefore also estimate the cost per new adopter ‚Äì a necessary metric for
evaluating the efficacy of this incentive scheme.

2See

for example, http://thehealthcareblog.com/blog/2012/08/06/numbers-dont-lie-the-ehr-market-mustconsolidate/.
3 Because adoption by system hospitals may be decided by corporate parents, we primarily focus our analysis on
independent hospitals.

3

The stylized facts suggest that HITECH encouraged adoption by at least some hospitals.
Time series evidence shows a marked increase in adoption following the passage of HITECH. As of
2008, about 48 percent of independent hospitals and 55 percent of system hospitals had adopted at
least one of two advanced EMR technologies, physician documentation (PD) and computerized
practitioner order entry (CPOE). By 2011, these adoption rates for both independent and system
members had risen to 77 percent. 4
The coincident timing of this increase provides only suggestive evidence about the causal
role of HITECH in EMR adoption. Prior to the passage of HITECH, EMR adoption had been
steadily rising, so at least part of the growth is simply the continuation of this pre-existing trend. In
addition, while on its face $27 billion is a substantial pool of funds, it was not exclusively targeted
towards new adopters. Hospitals that had previously installed EMR were also eligible for this
program, suggesting that the incentive payments for new adopters were far smaller. If a large market
failure was actually creating a meaningful difference between the costs and benefits of EMR
adoption for the hospitals which had not installed EMR by 2009, it is possible these smaller
payments for new adopters may not bridge the gap.
As noted above, adoption rates for all independent hospitals grew to 77 percent by 2011.
Absent HITECH incentives, we estimate that the adoption rate would have instead been 67 percent.
Thus, HITECH promoted adoption among independent hospitals by an additional 10 percentage
points. While this may seem like a substantial effect, when we consider that HITECH funds were
available for all hospitals and not just marginal adopters, we estimate that the cost of generating an
additional adoption was $48 million, which is more than enough to cover the cost of a generous
EMR system. We also estimate that in the absence of HITECH incentives, the 77 percent adoption
rate would have been realized by 2013, just 2 years after the date achieved due to HITECH.
Notwithstanding the potential benefits of ‚Äúmeaningful use,‚Äù our findings suggest that
HITECH‚Äôs subsidies were not a particularly cost effective way to spur EMR adoption.
Understanding the role of government funds to spur the adoption of technology is important for
reasons beyond simply evaluating the efficacy of HITECH. Future attempts at solving market
failures within healthcare may require meaningful government investments, and it is therefore critical
to understand the effect of incentive payments in this economic context.

4

Authors‚Äô calculation using HIMSS data.

4

2. HITECH Act
Congress passed HITECH in February 2009 as part of the American Recovery and
Reinvestment Act. HITECH authorized Medicare and Medicaid incentive payments totaling up to
$27 billion to clinicians and hospitals when they use EMR to achieve specified improvements in care
delivery. In order to qualify for the incentive payments, providers must own an EMR system
certified specifically for the EMR Incentive Programs and demonstrate ‚Äúmeaningful use‚Äù of the
technology. Meaningful use requirements include a set of core objectives such as electronic entry of
clinical information, patient demographics, active medications allergies, diagnoses and smoking
status. Clinicians must employ clinical decision support tools, use EMR to enter clinical orders and
prescribe medications, and provide patients with an electronic copy of their health information on
request. Importantly, these incentives payments were available to hospitals that had EMR prior to
the passage of the legislation.
We focus on the effect of incentive payments on the decision to adopt EMR and not on the
role of meaningful use standards on hospital behavior. We do this for two primary reasons. First,
most hospitals with EMR state that they have or are determined to meet meaningful use
requirements and receive HITECH incentive payments (Botta and Cutler, 2014). Second, and more
practically, it is difficult to measure whether a hospital has met these standards in available data.
Hospitals can receive incentive payments from the Medicare and/or Medicaid programs.
Roughly speaking, the size of the incentive payment is a function of the percentage of the hospital‚Äôs
inpatients covered by Medicare or Medicaid and the total number of number of inpatient acute care
discharges. We describe the precise payment rules in Section 3.3. Hospitals receive the full incentive
payment in the first year after meeting meaningful use requirements. The payment is then multiplied
by a ‚Äútransition factor‚Äù that effectively reduces the incentive payments by 25 percentage points each
year. Hospitals can receive up to four years of payments from each of the two incentive programs 5
Thus, hospitals will normally receive a total of 250 percent of the first year payment. Hospitals can
begin receiving Medicaid incentives in any year from 2011 to 2016 and can receive Medicare
incentive payments in any year from 2011 to 2015, although those who started in 2014 or later will
receive a reduced Medicare payment. Providers must meet meaningful use requirements every year
to receive the incentive and to avoid an adjustment in their Medicare reimbursement payment,

Medicaid payments are calculated for a ‚Äútheoretical‚Äù 4-year period, but the amount can be paid over a minimum of a
three-year period and a maximum of a six-year period.

5

5

which will be applied to Medicare eligible hospitals who are not meaningful users starting from
October 1st, 2014. 6
The formulae for computing Medicare and Medicaid subsidies differ in a handful of ways.
The Medicare incentive is linear in Medicare utilization and is computed contemporaneously with
utilization; i.e. payments for a given year are based on Medicare utilization for that year. In contrast,
Medicaid incentive payments are based on a one-time calculation using data from the year prior to
the one in which a hospital starts receiving incentive payments. 7 Perhaps more importantly, hospitals
must reach a 10 percent Medicaid patient volume threshold to receive any payments. 8 The Medicaid
share is based on a 90 day ‚Äúreporting period.‚Äù Hospitals need only reach the 10 percent threshold
during one reporting period to be eligible for the incentive payments for the entire year.
3. Data
We compile data from three main sources. Data on adoption decisions and hospital
characteristics come from the Healthcare Information and Management Systems Society (HIMSS)
Analytics data base. We derive estimates of HITECH incentive payments using data from the
Medicare Healthcare Cost Report Information System (HCRIS). We limit the incentive calculation
to the pre-HITECH period (i.e. 2006-2008) so that we may account for endogeneity problems that
might arise if hospitals manipulate their patient composition in order to boost incentive payments.
As we describe below, such manipulation is not costless, and by using pre-HITECH utilization data,
we can directly model the costs of manipulation and the net benefits of HITECH‚Äôs subsidies. We
determine whether a hospital belongs to a health system using American Hospital Association
(AHA) data. Finally, we construct a number of controls using data from the AHA and the United
States Census.

3.1 EMR Adoption
The Healthcare Information and Management Systems Society (HIMSS) Analytics Dataset is
the industry standard for information on EMR adoption (e.g. Dranove et al., 2014; McCullough et
Non-CAH hospitals who are not meaningful users will receive a reduced update to the Inpatient Prospective Payment
System (IPPS) standardized amount (IPPS) payment rate for these hospitals. The reduction is 25% in 2015 and gradually
increases to 75% for 2020 and later. see http://www.cms.gov/Regulations-andGuidance/Legislation/EHRIncentivePrograms/Downloads/PaymentAdj_HardshipExcepTipsheetforHospitals.pdf
7 Medicaid payments are calculated for a ‚Äútheoretical‚Äù 4-year period; the amount is paid over a minimum of a three-year
period and a maximum of a six-year period.
8 Certain types of hospitals, such as children‚Äôs hospitals are exempted from meeting the 10% threshold.
6

6

al., 2013; and Miller & Tucker, 2009). HIMSS data report adoption status and implementation
history of over 100 Health Information Technology applications, in a variety of categories, for more
than 5300 healthcare providers. We focus on applications in the ‚ÄúElectronic Medical Records‚Äù
category. Previous studies categorize these applications into ‚Äúbasic‚Äù and ‚Äúadvanced‚Äù EMR (e.g.
Dranove et al., 2014). Basic EMR, such as Clinical Decision Support and Clinical Data Repository,
are relatively easy to implement and were widely adopted prior to HITECH. Advanced EMRs ‚Äì
Physician Documentation and Computerized Physician Order Entry (CPOE) ‚Äì are both costly and
complex. Adoption costs vary by the size of the hospital and sophistication of the applications, but
generally exceed $10 million and can go much higher. 9 Advanced EMRs contain key functionalities
that are critical for hospitals to achieve meaningful use. For example, hospitals must use CPOE for
medication orders for more than 30 percent of patients taking medications (Blumenthal and
Tavenner, 2010). For these reasons, we examine the effect of HITECH incentive payments on
hospitals‚Äô adoptions of advanced EMR.
We define the adoption of advanced EMR as a dummy variable that equals 1 if the hospital
has adopted CPOE or Physician Documentation. The adoption year is defined as the ‚Äúcontract
year,‚Äù i.e. the year in which a hospital first entered a contract with their EMR vendor. Figure 1
shows the cumulative adoption rate of advanced EMR for independent hospitals and system
hospitals that meet the sampling restrictions described below. Cumulative adoption rates are higher
among system hospitals than independent hospitals. After an initial surge, adoption rates level off in
about 2006, and then increase again after HITECH. Both samples show an uptick in adoption
following the implementation of HITECH, with a bigger increase for independent hospitals, so that
the gap disappears by 2011. Given that the initially swift adoption rate is likely indicative of the
decisions of a specific set of early adopter hospitals, in our empirical analysis we compare adoption
in the post-HITECH period with adoption in the more stable pre-period of 2006-2008. This trend
more closely represents the adoption pattern of the remaining hospitals as of the passage of
HITECH.

3.2 Sample Restrictions
Table 1 details the effect of a series of restrictions on sample size. We begin with the full
sample of hospitals in the AHA data base. Only short term acute care hospitals are eligible for
9

Based on personal conversations with chief technology officers at various hospitals and health IT consultants.

7

HITECH incentive payments so we remove all other hospitals from the sample. We are able to
match the vast majority of these hospitals to HCRIS and use the HCRIS data to compute incentive
payments. 10 We exclude Critical Access Hospitals because they are subject to a different set of
incentive payments that are not easy to compute with available data. 11 Similarly, we eliminate
Children‚Äôs Hospitals because they are exempted from the 10 percent Medicaid patient volume
threshold requirement and are likely to differ from general acute care hospitals in their financing and
objectives. Excluding Critical Access and Children‚Äôs Hospitals eliminates approximately 25 percent
of our sample. Finally, we restrict our sample to hospitals with non-missing adoption data in
HIMSS.
EMR adoption by system hospitals may be made by corporate parents and likely represents a
decision that is beneficial for the entire system and not one specific facility. It can therefore be
difficult to compute the effective HITECH incentives for individual members of a system. Thus, we
focus our attention on hospitals that did not belong to systems in 2008. 12 The vast majority of these
hospitals remained independent in 2011, and our results are qualitatively similar for a sample of
hospitals that remain independent in all years.

3.3 HITECH Incentives
We measure each hospital‚Äôs HITECH incentive by calculating the additional payments from
Medicaid and Medicare that the hospital would expect to receive in its first year of eligibility as a
percentage of its operating costs. As discussed earlier, hospitals that achieve meaningful use by 2015
will receive total incentive payments that are approximately 250 percent of their first year payment.
Medicare and Medicaid rely on different formulae to determine incentive payments. Both
payments depend upon the hospital‚Äôs share of Medicare or Medicaid, respectively, as well as the total
number of all discharges. The variable discharges is the average number of discharges that a hospital
has per year for 2006-2008. Similarly, % Medicare and % Medicaid equal the share of a hospital‚Äôs
inpatient bed days from each government payer (adjusted by the share of non-charity care) for the
We also dropped around 0.5% of the sample due to ‚Äúinvalid‚Äù value for incentive payments, i.e. Medicaid or Medicare
share greater than 1, or charity charges greater than total charges. We consider them as data errors.
11CAHs are reimbursed by Medicare based upon ‚Äúreasonable costs‚Äù, with Medicare paying a share of reasonable costs
increasing in the hospital‚Äôs Medicare share. They receive (ùëüùëíùëéùë†ùëúùëõùëéùëèùëôùëí ùëêùëúùë†ùë°ùë†) ‚àó (.2 + % ùëÄùëíùëëùëñùëêùëéùëüùëí) if ‚àó (. 2 +
% ùëÄùëíùëëùëñùëêùëéùëüùëí) < 1 and their reasonable costs otherwise. Looking at actual reimbursements to CAHs, they are only
minimally correlated with Medicare share and with measures of size.
12 Results remain similar if we restrict our sample to hospitals that are always independent.
10

8

pooled 2006-2008 time period. Payments under the Medicare and Medicaid program are a function
of discharges and take the following form:
ùëì(ùëëùëñùë†ùëê‚Ñéùëéùëüùëîùëíùë†) = 2,000,000
= 1,770,000 + 200 ‚àó ùëëùëñùë†ùëê‚Ñéùëéùëüùëîùëíùë†
= 4,370,200
The formula for the Medicare incentive payment is 13:

If ùëëùëñùë†ùëê‚Ñéùëéùëüùëîùëíùë† < 1150
If ùëëùëñùë†ùëê‚Ñéùëéùëüùëîùëíùë† ‚àà (1150,23000)
If ùëëùëñùë†ùëê‚Ñéùëéùëüùëîùëíùë† > 23000

$ ùëÄùëíùëëùëñùëêùëéùëüùëí ùëñùëõùëêùëíùëõùë°ùëñùë£ùëíùë† = ùëì(ùëëùëñùë†ùëê‚Ñéùëéùëüùëîùëíùë†) ‚àó (% Medicare)

The Medicaid incentive payments are calculated in the following manner:

$ ùëÄùëíùëëùëñùëêùëéùëñùëë ùëñùëõùëêùëíùëõùë°ùëñùë£ùëíùë† = ùëì(ùëëùëñùë†ùëê‚Ñéùëéùëüùëîùëíùë†) ‚àó (% Medicaid) ‚àó I[% Medicaid > 10%] 14
13F

In our analysis below, we note that the statutory threshold of 10 percent of patients from Medicaid
is not completely binding in practice. In many states the Medicaid report period is relatively short
and well known to hospitals. Therefore, hospitals near the threshold can potentially alter their
patient flow over that short term and thus may view the Medicaid incentive payment as essentially
continuous.
In our results below we first present estimates using the statutory incentive schedule. We
then present our preferred specification, where we smooth the discontinuity in the payment formula
for Medicaid incentives in the following manner. First, we assume that hospitals can admit as many
Medicaid patients as they desire. Second, we calculate from the HCRIS data that the average cost of
treating each patient is $7,000. Medicaid has long been thought to pay less than the cost of providing
care. In 2009, the American Hospital Association (AHA) estimated this underpayment was 89
percent of costs, suggesting that Medicaid pays $6,230 per patient. 15 Using this information,
Medicaid incentive payments for hospitals are calculated as the payment amount (after bringing
additional Medicaid patients to achieve the 10% threshold) minus the loss resulting from treating
these patients (i.e. 11%*$7,000 per patient), as long as the value is non-negative. Using this
continuous measure of Medicaid incentive payments, 86.1 percent of the hospitals whose Medicaid

13 In particular, we use as our starting point the formula that CMS says it is using for reimbursements:
https://questions.cms.gov/faq.php?id=5005&faqId=3377
There was a major cost report redesign in 2010, and while CMS provides a formula for pre-2010, it relies upon fields
that are not reported pre-2010. We use an altered formula that allows us to both reproduce the recommended formula
for 2010+, and at the same time apply the formula to prior years.
14 States have leeway in determining how % Medicaid is calculated. We abstract from this, calculating % Medicaid from
the Cost Reports using a methodology analogous to the one we use for calculating % Medicare.
15 According to the American Hospital Association‚Äôs, ‚ÄúUnderpayment by Medicare and Medicaid Fact Sheet‚Äù (December
2010). Access from: http://www.aha.org/content/00-10/10medunderpayment.pdf

9

shares are below the 10% threshold are expected to receive a non-zero incentive payment should
they adopt advanced EMR.
To validate our measures, we compared our predicted incentive payments to the actual
Medicare payments and to the Medicaid payments in the states where incentive payment data is
available (New York and Arizona). Appendix Figure 1 contains scatter plots for these outcomes and
shows a very strong relationship between our continuous measure and actual payments.
Hospitals may differ in their response to incentive payments. Both the benefits and costs of
adoption may depend on the total number and complexity of patients that a hospital treats. In order
to account for this heterogeneity across hospitals, we standardize the incentive payments using
hospitals‚Äô operating costs. We control for a hospital‚Äôs number of beds, teaching status and for-profit
status.. We also include interaction terms of these controls with the dummy variable indicating the
policy change to allow a differential effect of these controls before and after HITECH. Finally, we
include yearly county-level unemployment rate from the Bureau of Labor Statistics (BLS) to control
for changes in the local economy.
4. Results
Table 3 provides summary statistics for the components of HITECH incentives, as well as
other variables that might affect adoption. To better illustrate the sources of variation affecting our
measure of incentives, Figure 2 plots the distributions of the incentive measures. Given the variation
in Medicaid and Medicare share by hospital, it should not be surprising that our measure of total
incentives shows a great deal of dispersion, both in absolute terms and as a percentage of operating
costs.
To calculate the effect of HITECH on the adoption decision of hospitals we estimate a
series of Cox proportional hazard models. We define ùêªùêºùëáùê∏ùê∂ùêªùëñ to be the level of HITECH

incentive payments for hospital i. Our primary goal is to determine whether hospitals that had larger
payments under HITECH experienced a larger increase in their adoption likelihoods after HITECH
relative to hospitals with smaller payments. To do this, we estimate a model where the probability
that a hospital that has not adopted by t-1 adopts by t is:
(1)

‚Ñé(ùë°) = ‚Ñé0 (ùë°)ùëí ùúÜ(ùêªùêºùëáùê∏ùê∂ùêªùëñ )+ùúÜùë°‚àóùêº(ùë¶ùëíùëéùëü=ùë°)‚àó(ùêªùêºùëáùê∏ùê∂ùêªùëñ )+ùëãùëñ ùõΩùë°‚àóùêº(ùë¶ùëíùëéùëü=ùë°)

In this equation, ùúÜ gives the average effect of ùêªùêºùëáùê∏ùê∂ùêªùëñ on adoption in 2006 (our base year) and ùúÜùë°

gives the additional effect on adoption in year t relative to 2006 and ‚Ñé0 (ùë°) is a baseline hazard
10

function for hospitals in year t, which is allowed to vary nonparametrically with t. We include a
number of controls (ùëãùëñ ) that were discussed above.

Table 4 presents our estimates of equation (1). Columns (1) and (2) contain the estimates

using the statutory definition of the Medicaid incentive system with the latter estimates including
time varying control variables. Our preferred specification, which accounts for the fact that hospitals
have some control over their Medicaid population, is contained in columns (3) and (4). In both sets

of results, the coefficient Œª (i.e., the effect of HITECH for the base year 2006) is less than one. This
indicates that as of 2006, hospitals that would ultimately be presented with stronger HITECH
incentives were less likely to adopt. This suggests that HITECH appears to have effectively targeted
marginal as opposed to inframarginal hospitals.
Figure 3 plots the coefficients Œªt and their confidence intervals. The coefficients are stable
for 2006-2008, but they increase substantially in 2009 and 2010. Thus, HITECH‚Äôs incentives did not
affect adoption prior to the start of the program. Following the implementation of HITECH,
however, the incentives were associated with higher adoption rates than would have been expected
in the absence of the program. This suggests that HITECH incentives had a causal effect on
adoption. Of course, the confidence intervals in Figure 3 are quite large. To produce a more precise
estimate of HITECH‚Äôs effect, we run a pooled version of the prior regression:
(2) ‚Ñé(ùë°) = ‚Ñé0 (ùë°)ùëí ùúÜ(ùêªùêºùëáùê∏ùê∂ùêªùëñ )+ùúÜùëùùëúùë†ùë°‚àóùêº(ùë¶ùëíùëéùëü>2008)‚àó(ùêªùêºùëáùê∏ùê∂ùêªùëñ )+ùëãùëñ ùõΩ+ùëãùëñ ùõΩùëùùëúùë†ùë°‚àóùêº(ùë¶ùëíùëéùëü>2008)

Panel A of Table 5 presents estimates of equation (2). Column (1) and (2) shows the result

using the total HITECH incentive payments calculated based on actual (discontinuous) Medicaid
payments, with and without interactions between our controls and the post period. We replace
actual incentives with values after smoothing discontinuity in Medicaid payments in Column (3) and
(4), and get very similar results. Our coefficient estimate of the post-2008 effect of HITECH is
approximately 1.12, implying that a hospital receiving HITECH payments in a given year amounting
to one percent of its operating costs would increase its adoption probability by about 12 percent in
each year.
The coefficient of approximately 1.7 in the fourth row of Panel B implies that HITECH
incentives cause the average hospital to increase its adoption probability by approximately 70
percent above the baseline annual hazard rate of 9.6 percent for 2006-2008. The 95 percent
confidence interval for the estimate is quite large, but we can rule out increases of less than 22
percent.

11

Figure 4 plots the actual cumulative adoption rates of independent hospitals, our model
predictions, and our model predictions had HITECH not happened (i.e., the counterfactual). Our
model predicts that HITECH caused an additional 10 percent of hospitals to adopt advanced EMR.
In Figure 5, we fit the counterfactual adoption rate to a logistic model in which we predict
the post-2011 adoption rates without HITECH. We find that had HITECH not been passed, the
adoption rate would have reached the same level as the actual 2011 adoption rate in 2013, i.e.
HITECH accelerated adoption by two years.
Our findings do not materially change when we implement a number of alternative
specifications, which we show in Appendix Table 1. In particular, we: (1) restricted ‚Ñé0 (ùë°) to be a
Weibull distribution; (2) and (3) generated hospital incentives using the 2009-2011 (i.e. post-

HITECH) cost reports with and without smoothing the discontinuity in Medicaid incentives; (4)

changed the length of reporting period from 1 year to 3 months when calculating the continuous
measure of Medicaid incentive; (5) changed our measure of adoption to having both of the advanced
EMR applications; (6) restricted the analysis to hospitals that are never a part of a system. The
marginal effect of HITECH on adoption across these specifications varies from 1.32 to 1.75.
In our main analysis, we restricted our sample to independent hospitals for two primary
reasons. First, system and independent hospitals may face different costs and benefits of EMR
adoption. For example, a system may have larger benefits to coordinating referrals therefore be
more likely to adopt than independent hospitals. If system hospitals and independents differ on
observables, but also on unobservables that affect adoption (like the value of better coordination),
then pooling the two groups will result in biased estimates. The second reason for restricting the
analysis to independent hospitals is that the adoption decisions for hospital within a system are
interconnected with the adoption decisions of other hospitals within the system, which makes it
difficult to measure the benefits of adoption for each system hospital individually.
5. Discussions and Conclusions
Many prior studies find that government subsidies fully crowd out private investments. In
contrast, we find that HITECH increased the cumulative adoption of advanced EMR among
independent hospitals by 10 percentage points in a short period of time. Given that slightly over half
of independent hospitals had advanced EMR by 2008, this implies that HITECH accelerated EMR
adoption by more than one in five non-adopters. This is not surprising. Based on the limited pricing
information that is available, the cost of installing and operating an EMR system by an average-sized
12

hospital is at least $10 million and could be much higher. The average non-adopter as of 2008 could
have expected to receive $2.1 million in HITECH subsidies for the first year and $5.3 million in
total. If adopters were at the high end of the subsidy spectrum, then incentive payments could be
higher than $10 million ‚Äì though it should be noted that many of these hospitals may also face
higher costs of adopting advanced EMR. Thus, HITECH incentives represented a sizable
percentage of total adoption costs.
It is tempting to interpret these results as an unmitigated success, i.e. HITECH spurred
adoption while only paying a fraction of the cost of these new systems. By revealed preference we
can infer that the marginal adopters (i.e., adopters who would have remained on the sideline in the
absence of HITECH incentives) believe that EMR contributed some value to their organization but
were unable to adopt the technology without substantial incentive payments. 16 However, there are
two reasons to take a more skeptical view of the merits of HITECH.
First, it may have been politically impractical to dedicate HITECH funds to these marginal
adopters, both because this may have been seen as unfair to early adopters and also because
HITECH incentives are also used to promote meaningful use. As a result, total HITECH payments
dwarfed the subsidies to marginal adopters. It is instructive to compute the total HITECH subsidies
per adopting hospital. We estimate that 67 percent of hospitals would have adopted by 2011 without
HITECH and that 10 percent of hospitals adopted because of HITECH. The average incentive
payments to all independent hospital that adopted EMR by 2011 is $6.2 million, so it costs $48
million ($6.2 million * (0.77/0.10)) in incentive payments for each adopting hospital in our sample to
generate a single additional adoption. This more than covers the typical implementation costs and
maintenance costs over first few years for the average sized hospital. As mentioned, such an expense
was inevitable given the impracticality of restricting subsidies to marginal adopters and also helped
encourage meaningful use among all hospitals. The importance of political considerations cannot be
understated in this setting because future attempts to provide incentives for hospitals to adopt other
programs will face similar political pressures.
Second, these HITECH funds may have simply accelerated an ongoing trend, and therefore
the rate of adoption realized by 2011 would have been achieved soon thereafter ‚Äì by 2013 according
to our estimates ‚Äì without HITECH funds. Again notwithstanding meaningful use, the expenditures
of HITECH appear to have simply provided two additional years of EMR use at facilities that may
The debatable value of these systems to these hospitals can also be seen in Dranove, Garthwaite, and Ody (2013)
where hospitals suffering financial shocks delay their adoption of EMR.

16

13

have been unsure about the product‚Äôs ultimate value. Given that hospitals are still trying to figure
out how to systematically use HIT to boost quality and reduce costs, briefly accelerating adoption at
this juncture is not obviously desirable. Thus, it may be better to ultimately judge HITECH on the
impact of meaningful use requirements on outcomes such as costs and quality, something that has
yet to be determined. And if meaningful use is the ultimate goal, it seems quite possible that this
could have been achieved at a much lower cost. For example, HITECH already includes penalties in
the former of lower Medicare reimbursements for hospitals that do not meet meaningful use
standards after 2015.

14

References
Agha, L. 2014. ‚ÄúThe effects of health information technology on the costs and quality of medical
care,‚Äù Journal of Health Economics, 34: 19-30.
ARRA. 2009. ‚ÄúAmerican Reinvestment and Recovery Act.‚Äù 111-5 Public Law.
Blumenthal, D., and M. Tavenner. 2010. ‚ÄúThe Meaningful Use Regulation for Electronic Health
Records," New England Journal of Medicine, 363(6), 501-504.
Botta, M. and D. Cutler. 2014. ‚ÄúMeaningful Use: Floor or Ceiling,‚Äù Healthcare 2(1): 48-52.
Buntin, M. and D. Cutler. 2009. ‚ÄúThe Two Trillion Dollar Solution,‚Äù Center for American Progress.
http://www.americanprogress.org/issues/2009/06/pdf/2trillion_solution.pdf.
Culter, D., Huckman, R., and Landrum, M. 2004. ‚ÄúThe Role of Information in Medical Markets: An
Analysis of Publicly Reported Outcomes in Cardiac Surgery.‚Äù The American Economic Review, 95(2):
342‚Äì346.
DesRoches, C., Campbell, E., Vogeli, C., Zheng, J., Rao, S., Shields, A., Donelan, K., Rosenbaum,
S., Bristol, S. and A. Jha. 2009. ‚ÄúElectronic Health Records‚Äô Limited Successes Suggest More
Targeted Uses,‚Äù Health Affairs, 29(4): 639-646.
Dranove, D., Forman, C., Goldfarb, A. and S. Greenstein. 2013. ‚ÄúThe Trillion Dollar Conundrum:
Complementarities and Health Information Technology,‚Äù forthcoming, American Economic Journal:
Economic Policy.
Dranove, D., Garthwaite, G. and C. Ody. 2013. ‚ÄúHow do Hospitals Respond to Negative Financial
Shocks? The Impact of the 2008 Stock Market Crash,‚Äù NBER Working Paper #18853.
Freedman, S., Haizhen L. and J. Prince. 2014. ‚ÄúInformation Technology and Patient Health: An
Expanded Analysis of Outcomes, Populations, and Mechanisms,‚Äù mimeo Indiana University.
Gartner, 2010, Perspective: IT Spending, at
http://www.financialexecutives.org/eweb/upload/FEI/Gartner.pdf searched 5/21/2014
Gonzalez, X, and C. Pazo. 2008. ‚ÄúDo Public Subsidies Stimulate Private R&D Spending?‚Äù Research
Policy, 37(3): 371-89.
Goolsbee, A. 1998. ‚ÄúInvestment Tax Incentives, Prices, and the Supply of Capital Goods‚Äù Quarterly
Journal of Economics, 113(1): 121-48.
Hanlon, M. and S. Heitzman. 2010. ‚ÄúA Review of Tax Research‚Äù Journal of Accounting and Economics
50(2): 127-78.
Hassett, K. and G. Hubbard. 2002. ‚ÄúTax Policy and Business Investment‚Äù in Auerbach, A. and M.
Feldstein (eds), Handbook of Public Economics, 1294-1343. Amsterdam: Elsevier.
15

Hillestad, R., Bigelow, J., Girosi, F., Meili, R., Scoville, R. and R. Taylor. 2005. ‚ÄúCan electronic
medical record systems transform health care? Potential health benefits, savings, and costs,‚ÄùHealth
Affairs, 24(5): 1103‚Äì1117.
Himmelstein, D., Wright, A. and S. Woolhander. 2010. ‚ÄúHospital Computing and the Costs and
Quality of Care: A National Study,‚Äù The American Journal of Medicine, 123(1): 40-46.
Institute of Medicine. 2001. Crossing the Quality Chasm: A New Health System for the 21st Century.
Washington, D.C.: National Academy Press.
Lech, S. 2002, ‚ÄúDo R&D Subsidies Stimulate or Displace Private R&D? Evidence from Israel‚Äù
Journal of Industrial Economics 50(4): 369-90.
Lee, J., McCullough, J.S. and R. Town. 2013. ‚ÄúThe Impact of Health Information Technology in
Hospital Productivity,‚Äù Rand Journal of Economics, 44(3): 545-568.
McCullough, J.S., Casey, M , Moscovice, I. and S Prasad. 2010. ‚ÄúThe Effect of Health Information
Technology on Quality in U.S. Hospitals,‚Äù Health Affairs, 29(4): 647-54.
McCullough, J.S., Parente, S. and R. Town. 2013: ‚ÄúHealth Information Technology and Patient
Outcomes: The Role of Organizational and Informational Complementarities," Discussion paper,
National Bureau of Economic Research.
Miller, A.R., and C. Tucker. 2009. ‚ÄúPrivacy protection and technology diffusion: The case of
electronic medical records," Management Science, 55(7), 1077-1093.
Miller, A.R, and C. Tucker. 2011. ‚ÄúCan Health Care Information Technology Save Babies?,‚Äù The
Journal of Political Economy 119(2): 289-324.
Pack, H. and K. Saggi. 2006. ‚ÄúIs There a Case for Industrial Policy? A Critical Survey‚Äù World Bank
Economic Review 21(2): 267-97.
Peltzman, S. 1973. ‚ÄúThe Effect of Government Subsidies-in-Kind on Private Expenditures: The
Case of Higher Education‚Äù Journal of Political Economy, 81(1): 1-27.
Wallsten, S., 2000. ‚ÄúThe Effects of Government-Industry R&D Programs on Private R&D: The
Case of the Small Business Innovation Research Program‚Äù RAND Journal of Economics, 31(1): 82-100.

16

Figure 1: Cumulative Hospital Advanced EMR Adoption Rates
80%

Percent of Hospitals with Advanced EMR

70%

60%

System
Hospitals
50%

40%

30%

Independent
Hospitals

20%

10%

0%
2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

Figure 2: Distributions of Components of Incentive Measure
Medicare Incentive ($ million)
.15

Fraction

0

.2

.4

.6

.8

1

0

0

0

.02

.05

.04

Fraction

.06

.1

.08

.08
.06
.04
.02

Fraction

Operating Costs ($ million)

.1

% Medicare

0

Medicare Share

1

2

3

4

0

Medicare Incentives ($ million)

Medicaid Incentive ($ million)

400

600

Total Incentive*100/ Operating Costs

.05

.1

Fraction

.06
.04

Fraction

.04

0

0

.02

.02
0

Fraction

.06

.08

.15

.1

.08

% Medicaid

200

Total Operating Costs ($ million)

0

.2

.4

.6

Medicaid Share

.8

1

0

1

2

3

Medicaid Incentives ($ million)

4

0

5

10

15

Total Incentive*100/ Operating Costs

20

Figure 3: Time-Varying Effect of HITECH Incentives on Advanced EMR Adoption Rates

1.3

Coeffieicnts (Hazard Ratios)

1.2

1.1

1.0

0.9

0.8
2006

2007

2008

2009

2010

2011

Notes: Coefficients are from Column (2) in Table 4, and include as controls Country-Level Unemployment Rate, yearly interactions with ln(No of Beds), Profit Status,
Teaching Status. Coefficients are multiplicative changes in the probability of adoption relative to 2006.

Figure 4: Effect of HITECH on Cumulative Hospital Advanced EMR Adoption Rates

Percent of Hospitals with Advanced EMR

80%

Predicted
Adoption Rate

70%

60%

50%

Actual
Adoption Rate

Counterfactual
Adoption Rate

40%

30%

20%
2004

2005

2006

2007

2008

2009

2010

2011

Notes: Number of Hospitals=854. Predictions and Counterfactual are based on regression output from
Table 5, Column (4).

Figure 5: Effect of HITECH on Cumulative Hospital Advanced EMR Adoption Rates

Percent of Hospitals with Advanced EMR

100%
90%

Actual
Adoption Rate

80%
70%

Counterfactual
(Extrapolated)
Adoption Rate

60%
50%
40%
30%
20%

Counterfactual
Adoption Rate

10%
0%
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

Notes: Number of Hospitals=854. Actual and Counterfactual are identical to results in Figure 4.
Counterfactual is based on regression output from Table 5, Column (4). Counterfactual (Extrapolated)
are the results from fitting the counterfactual to a logistic model.

Table 1: Impact of Sample Restrictions on Sample Size
2004 2005 2006
5,739 5,739 5,997
4,745 4,745 4,754
4,517 4,517 4,609
4,152 4,152 4,414

Observations in AHA data
Short Term Acute Care Hospitals
Matches to 2006-2011 HCRIS
Valid Incentive Payments
Non-Critical Access and Non-Children's
Hospitals
Matches to HIMSS
Final Sample (Clean Advanced EMR Adoption)
System and Independent Sample
Independent Sample

Adopted by Current Year
Full Sample
Share Adopted

2007
5,997
4,754
4,609
4,414

2008
5,952
4,729
4,593
4,451

2009
5,952
4,729
4,593
4,451

2010
5,952
4,729
4,593
4,451

2011
5,952
4,729
4,593
4,451

3,092 3,092 3,150 3,150 3,180 3,180 3,180 3,180
3,028 3,028 3,080 3,080 3,103 3,103 3,103 3,103
2,983 2,983 3,035 3,035 3,058 3,058 3,058 3,058
1,192 1,192 1,203 1,203 1,211 1,211 1,211 1,211

Table 2: Advanced EMR Adoption by Year
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
73
100
124
171
267
352
408
482
577
673
834
914
1,169 1,169 1,172 1,172 1,194 1,194 1,205 1,205 1,213 1,213 1,213 1,213
6%
9% 11% 15% 22% 29% 34% 40% 48% 55% 69% 75%

Table 3: Summary Statistics
Independent Variables
HITECH Incentive (100*$ Incentive/ $ Operating Costs)
Medicare
Medicaid (continuous)
Medicaid (discontinuous)
Total
HITECH Incentive ($ Million)
Medicare
Medicaid (continuous)
Medcaid (discontinous)
Total
Components of HITECH Incentive
Share Medicare
Share Medicaid
Average total discharges (1000)
Average total operating expenditure (million $)
Controls
Teaching
For Profit
Number of Beds
Number of hospitals
Notes: All variables are winsorized at mean ¬± 2.33*standard deviation

Mean
3.62
1.02
0.82
4.68
1.64
0.56
0.52
2.22

SD

Min

Max

4.09
1.03
0.97
4.97

0.08 17.74
0.00 4.34
0.00 3.92
0.21 21.23

0.65
0.46
0.50
0.90

0.12
0.00
0.00
0.16

3.37
2.14
2.17
4.73

0.55
0.17
6.86

0.13 0.22 0.85
0.11 0.00 0.48
7.64 0.004 63.31

115

128

4%
8%
159.9 134.9
854

1

603

4

614

Table 4: Cox Proportional Hazard Model Estimates of the
Effect of HITECH on Advanced EMR Adoption
(1)
(2)
(3)
0.850
0.883
0.846
HITECH Incentive
[-2.64]***

HITECH Incentive*(year==2006)
HITECH Incentive*(year==2007)
HITECH Incentive*(year==2008)
HITECH Incentives*(year==2009)
HITECH Incentives*(year==2010)
HITECH Incentives*(year==2011)
Medicaid Incentives
Controls*(Year Indicators)
Observations
Subjects
Adoptions

[-1.74]*

[-2.70]***

(4)
0.875
[-1.85]*

1.000

1.000

1.000

1.000

(constrained)

(constrained)

(constrained)

(constrained)

1.024

0.981

1.039

1.002

[0.31]

[-0.21]

[0.51]

[0.03]

1.057

1.017

1.068

1.034

[0.80]

[0.20]

[0.95]

[0.40]

1.120

1.086

1.127

1.097

[1.72]*

[1.04]

[1.81]*

[1.17]

1.163

1.131

1.170

1.143

[2.41]**

[1.64]

[2.49]**

[1.77]*

1.222

1.137

1.223

1.145

[3.15]***

[1.69]*

[3.16]***

[1.78]*

Continuous
N
3,860
854
560

Continuous
Y
3,860
854
560

Discontinuous Discontinuous
N
Y
3,860
3,860
854
854
560
560

Notes: Reported coefficients are Hazard Ratios. T-statistics are reported in [ ]. Years are 2006-2011. All models
control for ln(No of Beds), Profit Status, Teaching Status and Country-Level Unemployment Rate (not interacted with
year indicators in all models).
* P-value <= 0.10 ** P-value <=0.05 *** P-value <=0.01

Table 5: Cox Proportional Hazard Model Estimates of the
Effect of HITECH on Advanced EMR Adoption
Panel A: Model Results
(1)
(2)
(3)
HITECH Incentives

0.883
[-4.38]***

HITECH Incentives*(year>2008)

1.128
[4.22]***

Medicaid Incentives
Controls*(year>2008)
Observations
Subjects
Adoptions

0.886
[-3.76]***

1.122
[3.23]***

(4)

0.887

0.891

[-4.37]***

[-3.74]***

1.122

1.115

[4.20]***

[3.20]***

Discontinuous Discontinuous Continuous Continuous
N
Y
N
Y
3,860
3,860
3,860
3,860
854
854
854
854
560
560
560
560

Panel B: Interpreting Model Results
Effect of 1 SD Change in Incentives on Annual Adoption, 2009+
Point Estimate
1.77
1.72
1.36
1.24
95% CI
2.30
2.38
Effect of Full HITECH Incentives on Annual Adoption, 2009+
Point Estimate
1.72
1.68
1.34
1.23
95% CI
2.22
2.29

1.78
1.36
2.33

1.73
1.24
2.41

1.71
1.33
2.20

1.66
1.22
2.27

Notes: Reported coefficients are Hazard Ratios. T-statistics are reported in [ ]. Years are 2006-2011. All models
control for ln(No of Beds), Profit Status, Teaching Status and Country-Level Unemployment Rate (not interacted
with (year>2008) in any model).
* P-value <= 0.10 ** P-value <=0.05 *** P-value <=0.01

Appendix Figure 1: Expected vs Actual Incentive Payments
Panel B: Medicare 2012

4
3
2
1

0

0

1

2

3

4

Calculated Medicare Incentive ($ million)

5

5

Panel A: Medicare 2011

0

1

2
3
4
Actual Medicare Incentive ($ million)

0

5

Sample = 617, Correlation =.951

1

2
3
Actual Medicare Incentive ($ million)

4

5

Sample = 1,209, Correlation =.954

Panel D: Medicaid (NY and AZ) 2012

4
3
2
1

0

0

1

2

3

4

Calculated Medicaid Incentive ($ million)

5

5

Panel C: Medicaid (NY and AZ) 2011

0

1

2
3
4
Actual Medicaid Incentive ($ million)

Sample =106, Correlation =.951

5

0

1

2
3
4
Actual Medicaid Incentive ($ million)

5

Sample =125, Correlation =.970

Notes: The measure for calculated Medicaid incentives is continuous. Panel A and B include all hospitals (both system and independent) that actually
receive incentive payments in 2011 and 2012 respectively. Panel C and D only include hospitals in NY and AZ.

Appendix Table 1: Robustness Check
Effect of the HITECH Incentives on EMR Adoption
(1)
(2)
(3)
(4)
HITECH Incentive
HITECH Incentives*(year>2008)

Controls*(year>2008)
Observations
Subjects
Adoptions

(5)

(6)

0.923

0.893

0.89

0.891

0.844

0.894

[-3.19]***

[-3.47]***

[-3.44]***

[-3.74]***

[-3.43]***

[-3.60]***

1.061

1.106

1.112

1.116

1.142

1.113

[2.39]**

[2.78]***

[2.81]***

[3.21]***

[2.53]**

[3.14]***

Y
3,860
854
560

Y
3,860
854
560

Y
3,860
854
560

Y
3,860
854
560

Y
5,204
1,054
514

Y
3,582
797
532

1.74
1.24
2.43

1.86
1.15
3.01

1.72
1.23
2.41

1.68
1.22
2.30

1.75
1.14
2.70

1.65
1.21
2.26

Effect of 1 SD Change in Incentives on Annual Adoption, 2009+
Point Estimate
1.34
1.58
1.58
1.06
1.14
1.15
95% CI
1.71
2.18
2.17
Effect of Full HITECH Incentives on Annual Adoption, 2009+
Point Estimate
1.32
1.53
1.54
1.05
1.13
1.14
95% CI
1.65
2.06
2.08

Notes: Reported coefficients are Hazard Ratios. T-statistics are reported in [ ]. Years are 2006-2011. All models control for
ln(No of Beds), Profit Status, Teaching Status and Country-Level Unemployment Rate (not interacted with (year>2008) in any
model).(1) Restricted baseline hazard function to be distributed Weibull; (2) and (3) generate hospital incentives using the 20092011 (i.e. post-HITECH) cost reports with and without smoothing the discontinuity in Medicaid incentives; (4) changed the
length of reporting period from 1 year to 3 months when calculating the continuous measure of Medicaid incentive; (5) change
the measure of adoption to having both of the advanced EMR applications; (6) restrict to hospitals that are never a part of a
system.
* P-value <= 0.10 ** P-value <=0.05 *** P-value <=0.01

